Treatment of acute leukemia with L-asparaginase.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000596:Amino Acids / Q000097:blood; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001780:Blood Coagulation Tests; D001835:Body Weight; D002493:Central Nervous System Diseases / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D004342:Drug Hypersensitivity / Q000209:etiology; D005260:Female; D006801:Humans; D007938:Leukemia / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000139:chemically induced
D000596:Amino Acids; D001219:Aspartate Aminotransferases; D001215:Asparaginase; D001663:Bilirubin